Agios Pharmaceuticals, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| FARALLON CAPITAL MANAGEMENT LLC | 11/14/2024 | 5.66 M | $251.51 M | 0.11% | 9.94% |
| VANGUARD GROUP INC | 11/13/2024 | 5.55 M | $246.41 M | 0.90% | 9.74% |
| BLACKROCK FUNDING, INC. /DE | 11/13/2024 | 5.02 M | $223.12 M | 100.00% | 8.82% |
| BELLEVUE GROUP AG | 11/14/2024 | 3.74 M | $165.99 M | -3.70% | 6.56% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 11/14/2024 | 2.83 M | $125.85 M | 1.99% | 4.97% |
| STATE STREET CORP | 11/14/2024 | 2.33 M | $103.59 M | 10.24% | 4.09% |
| ARMISTICE CAPITAL, LLC | 11/14/2024 | 2.21 M | $98.06 M | 6.15% | 3.88% |
| 11/14/2024 | 2.18 M | $97.20 M | -3.10% | 3.84% | |
| JPMORGAN CHASE & CO | 12/26/2024 | 1.71 M | $76.11 M | -3.56% | 3.01% |
| MACQUARIE GROUP LTD | 11/14/2024 | 1.69 M | $75.12 M | -2.25% | 2.97% |
| DIMENSIONAL FUND ADVISORS LP | 11/07/2024 | 1.56 M | $69.41 M | -28.87% | 2.74% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2024 | 1.36 M | $60.33 M | 0.45% | 2.38% |
| MARSHALL WACE, LLP | 11/14/2024 | 1.26 M | $56.13 M | 11.43% | 2.22% |
| BVF INC/IL | 11/14/2024 | 1.19 M | $52.88 M | 0.00% | 2.09% |
| FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 11/15/2024 | 1.04 M | $46.39 M | 19.75% | 1.83% |
| POLAR CAPITAL HOLDINGS PLC | 11/14/2024 | 1.00 M | $44.52 M | 100.00% | 1.76% |
| BNP PARIBAS ASSET MANAGEMENT HOLDING S.A. | 11/08/2024 | 907,044 | $40.30 M | -0.45% | 1.59% |
| ARROWMARK COLORADO HOLDINGS LLC | 11/14/2024 | 882,731 | $39.22 M | -13.40% | 1.55% |
| FISHER ASSET MANAGEMENT, LLC | 11/12/2024 | 855,328 | $38.00 M | 20.48% | 1.50% |
| VESTAL POINT CAPITAL, LP | 11/14/2024 | 760,000 | $33.77 M | 100.00% | 1.33% |
| ROCK SPRINGS CAPITAL MANAGEMENT LP | 11/14/2024 | 699,389 | $31.07 M | -33.03% | 1.23% |
| GW&K INVESTMENT MANAGEMENT, LLC | 11/07/2024 | 630,946 | $28.03 M | 6.03% | 1.11% |
| LOOMIS SAYLES & CO L P | 11/13/2024 | 612,366 | $27.21 M | 36.43% | 1.08% |
| NORTHERN TRUST CORP | 11/13/2024 | 590,108 | $26.22 M | 0.66% | 1.04% |
| CALIGAN PARTNERS LP | 11/14/2024 | 579,717 | $25.76 M | 12.63% | 1.02% |
| D. E. SHAW & CO., INC. | 11/14/2024 | 532,404 | $23.65 M | -21.50% | 0.94% |
| GOLDMAN SACHS GROUP INC | 11/14/2024 | 476,657 | $21.18 M | -13.18% | 0.84% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/12/2024 | 465,620 | $20.69 M | 1.77% | 0.82% |
| PICTET ASSET MANAGEMENT HOLDING SA | 11/12/2024 | 400,849 | $18.28 M | -5.02% | 0.70% |
| ARTISAN PARTNERS LIMITED PARTNERSHIP | 11/12/2024 | 391,842 | $17.41 M | 22.27% | 0.69% |
| MORGAN STANLEY | 11/14/2024 | 348,973 | $15.50 M | -41.51% | 0.61% |
| BANK OF AMERICA CORP /DE/ | 11/14/2024 | 333,075 | $14.80 M | 1.93% | 0.59% |
| EAGLE HEALTH INVESTMENTS LP | 11/12/2024 | 330,830 | $14.70 M | 0.00% | 0.58% |
| CAPTION MANAGEMENT, LLC | 11/14/2024 | 300,000 | $13.33 M | 990.91% | 0.53% |
| PARKMAN HEALTHCARE PARTNERS LLC | 11/14/2024 | 285,099 | $12.67 M | -36.14% | 0.50% |
| CANDRIAM S.C.A. | 11/13/2024 | 261,505 | $11.62 M | -19.01% | 0.46% |
| AXA S.A. | 11/14/2024 | 238,750 | $10.61 M | 0.03% | 0.42% |
| BOOTHBAY FUND MANAGEMENT, LLC | 11/14/2024 | 233,056 | $10.35 M | 4.05% | 0.41% |
| TD ASSET MANAGEMENT INC | 11/01/2024 | 227,272 | $10.37 M | 7.98% | 0.40% |
| NORDEA INVESTMENT MANAGEMENT AB | 11/05/2024 | 212,976 | $9.71 M | -5.28% | 0.37% |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | 11/14/2024 | 196,399 | $8.73 M | -38.73% | 0.34% |
| CUTTER CAPITAL MANAGEMENT, LP | 11/14/2024 | 186,623 | $8.29 M | 100.00% | 0.33% |
| BARCLAYS PLC | 11/19/2024 | 180,417 | $8.02 M | 64.19% | 0.32% |
| BANK OF NEW YORK MELLON CORP | 11/12/2024 | 178,425 | $7.93 M | -20.04% | 0.31% |
| NUVEEN ASSET MANAGEMENT, LLC | 11/14/2024 | 162,741 | $7.23 M | -48.81% | 0.29% |
| CENTERBOOK PARTNERS LP | 11/14/2024 | 154,088 | $6.85 M | -38.19% | 0.27% |
| GRANAHAN INVESTMENT MANAGEMENT, LLC | 11/14/2024 | 150,785 | $6.70 M | 10.19% | 0.26% |
| POINT72 ASSET MANAGEMENT, L.P. | 11/14/2024 | 150,000 | $6.66 M | 100.00% | 0.26% |
| WALLEYE CAPITAL LLC | 11/14/2024 | 144,020 | $6.40 M | 623.36% | 0.25% |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | 11/13/2024 | 143,431 | $6.37 M | 4.05% | 0.25% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Agios Pharmaceuticals, Inc. institutional Ownership - FAQ's
During the previous two years, 281 institutional investors and hedge funds held shares of Agios Pharmaceuticals, Inc.. The most heavily invested institutionals were:
NORDEA INVESTMENT MANAGEMENT AB: 220,569
OAK RIDGE INVESTMENTS LLC: 38,869
HARBOR CAPITAL ADVISORS, INC.: 33,767
CONTRAVISORY INVESTMENT MANAGEMENT, INC.: 6,752
KBC Group NV: 2,615
Spire Wealth Management: 230
101.73% of Agios Pharmaceuticals, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 73.33 M shares in the last 24 months. This purchase volume represents approximately $2.47 B in transactions.